↓ Skip to main content

Dove Medical Press

Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin

Overview of attention for article published in Drug Design, Development and Therapy, October 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
27 Mendeley
Title
Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
Published in
Drug Design, Development and Therapy, October 2018
DOI 10.2147/dddt.s177316
Pubmed ID
Authors

Jun Li, Min Yang, Wen-Rong Xu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Student > Master 3 11%
Professor 2 7%
Student > Ph. D. Student 2 7%
Lecturer 2 7%
Other 3 11%
Unknown 10 37%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 26%
Medicine and Dentistry 2 7%
Business, Management and Accounting 1 4%
Nursing and Health Professions 1 4%
Chemistry 1 4%
Other 0 0%
Unknown 15 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2018.
All research outputs
#15,526,423
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#860
of 2,268 outputs
Outputs of similar age
#192,265
of 354,551 outputs
Outputs of similar age from Drug Design, Development and Therapy
#28
of 61 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,551 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.